Venous Thromboembolism in Advanced Disease
A clinical guide
Edited by Simon I R Noble, Miriam J Johnson, and Agnes Y Y Lee
Author Information
Dr Simon Noble is a Clinical Senior Lecturer and Honorary Consultant in Palliative Medicine, Cardiff University and the Royal Gwent Hospital in Wales. His research interests include the management of venous thromboembolism in advanced cancer and the anticancer effects of low molecular weight heparins. He has chaired the APM Task group for the management of VTE in palliative care and is a Trustee of Lifeblood: a UK-based thrombosis charity. Dr Miriam Johnson is a Senior Lecturer in Palliative Medicine at Hull-York Medical School and Honorary Consultant to St. Catherine's Hospice, North Yorkshire, UK. Her research interests include the management of venous thromboembolism in advanced cancer, which formed the basis of her MD thesis. Her other research interests include the palliative care of patients with end stage heart failure, and the symptom management of breathlessness. She was part of the APM Task group for the management of VTE in palliative care. Dr Lee is the co-principal investigator of the CLOT study (Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer), a landmark study that established low-molecular-weight heparin as the treatment of choice for preventing recurrent venous thromboembolism in cancer patients. Her current research activities include studies in catheter-related thromobosis, diagnosis of deep vein thrombosis and pulmonary embolism in pregnant women, and thromboprophylaxis in patients undergoing major orthpaedic surgery. She is also involved in translational research exploring the role of coagulation in cancer biology. She is a co-chair of the subcommittee on Hemostasis and Malignancy of the International Society of Thrombosis and Haemostasis and has chaired various educational sessions at annual meetings at the American Society of Hematology and the American Society of Clinical Oncology.
Contributors:
Aneel A. Ashrani, Assistant Professor of Medicine, Mayo Clinic College of Medicine, USA
Sara Booth, Macmillan Consultant in Palliative Care, Addenbrooke's Palliative Care Team, Cambridge, UK
Dawn Dowding, Senior Lecturer in Clinical Decision Making, University of York and Hull York Medical School, UK
John A. Heit, Director, Thrombophilia Center; Professor of Medicine, Mayo Clinic College of Medicine, USA
Menno V. Huisman, Department of General Internal Medicine, Leiden University Medical Center, The Netherlands
Beverley J Hunt, Department of Haematology, St Thomas's Hospital, London, UK
Miriam Johnson, Senior Lecturer in Palliative Medicine, Hull-York Medical School and Honorary Consultant to St. Catherine's Hospice, Scarborough, UK
Agnes Y. Y. Lee, Associate Professor, McMaster University, Canada
Sarah J. Lewis, Consultant Haematologist and Lead Clinician for Thrombosis, Royal Gwent Hospital, Cardiff, UK
Simon Noble, Senior lecturer in Palliative Medicine, Cardiff University and Royal Gwent Hospital, UK
Anna Spathis, Acting Consultant in Palliative Medicine, Bedfordshire, UK
Robert Weinkove, Department of Haematology, St Thomas's Hospital, London, UK